Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association

SV Arnold, DL Bhatt, GW Barsness, AL Beatty… - Circulation, 2020 - Am Heart Assoc
Although cardiologists have long treated patients with coronary artery disease (CAD) and
concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally been considered just a …

Drug-eluting coronary-artery stents

GG Stefanini, DR Holmes Jr - New England Journal of Medicine, 2013 - Mass Medical Soc
Drug-Eluting Coronary-Artery Stents | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

T Palmerini, G Biondi-Zoccai, D Della Riva, C Stettler… - The Lancet, 2012 - thelancet.com
Background The relative safety of drug-eluting stents and bare-metal stents, especially with
respect to stent thrombosis, continues to be debated. In view of the overall low frequency of …

[PDF][PDF] Coronary stents: historical development, current status and future directions.

J Iqbal, J Gunn, PW Serruys - British medical bulletin, 2013 - Citeseer
Coronary artery disease (CAD) is the leading cause of morbidity and mortality in the world.
Central to the pathogenesis of CAD is the development of atherosclerotic lesions in coronary …

A review of propensity-score methods and their use in cardiovascular research

S Deb, PC Austin, JV Tu, DT Ko, CD Mazer… - Canadian Journal of …, 2016 - Elsevier
Observational studies using propensity-score methods have been increasing in the
cardiovascular literature because randomized controlled trials are not always feasible or …

Coronary stents: current status

S Garg, PW Serruys - Journal of the American College of Cardiology, 2010 - jacc.org
Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data …

ML Berger, M Mamdani, D Atkins… - Value in health, 2009 - Wiley Online Library
Objectives: Health insurers, physicians, and patients worldwide need information on the
comparative effectiveness and safety of prescription drugs in routine care. Nonrandomized …

Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta …

J Daemen, E Boersma, M Flather, J Booth, R Stables… - Circulation, 2008 - Am Heart Assoc
Background—Randomized trials that studied clinical outcomes after percutaneous coronary
intervention (PCI) with bare metal stenting versus coronary artery bypass grafting (CABG) …

Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation

T Kimura, T Morimoto, Y Nakagawa, T Tamura… - Circulation, 2009 - Am Heart Assoc
Background—The influences of antiplatelet therapy discontinuation on the risk of stent
thrombosis and long-term clinical outcomes after drug-eluting stent implantation have not yet …

The Cardiovascular Health in Ambulatory Care Research Team (CANHEART) using big data to measure and improve cardiovascular health and healthcare services

JV Tu, A Chu, LR Donovan, DT Ko… - … Quality and Outcomes, 2015 - Am Heart Assoc
Background—The CArdiovascular HEalth in Ambulatory care Research Team (CANHEART)
is conducting a unique, population-based observational research initiative aimed at …